DFIN · Donnelley Financial Solutions, Inc.

Current Thesis

Donnelley Financial Solutions’ software transition supports a margin-expansion thesis that the Q3 2026 results must confirm before the market breaks the $44 weekly-close threshold. The operating test is software growth matching or exceeding Q2’s 7.8% year-over-year pace, total revenue above the $175 million guidance floor and an adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) margin of at least 26%. These are research conditions, anchored to the company’s 2026-07-30 results and guidance. Q2 release

The refresh changes the price assessment more than the operating case. The supplied adjusted market series records a $47.95 close on 2026-09-11, a three-month increase of 24.7% and a 14-period relative strength index (RSI) of 48.3. The retrieved company listing still identifies 2026-07-30 as its latest results release; no subsequent operating update was verified as of 2026-09-13. Investor relations

As an inference, the narrative is maturing — the 2026-07-30 operating evidence remains the anchor while the 2026-09-11 momentum reading offers no confirmation of renewed acceleration. This describes the evidence available, rather than measured investor participation. A subsequent report meeting the operating test alongside a close above the current adjusted 52-week high of $55.90 would contradict that assessment.

Bullish and bearish views on Donnelley Financial Solutions, Inc.

The model's bull view on Donnelley Financial Solutions, Inc. (DFIN), in brief: Software gained revenue share. The 2026-07-30 release reported Q2 software sales of $99.4 million, up 7.8% year over year, representing 44.3% of revenue versus 42.3% a year earlier. Q2 release Margins and cash improved. Q2 2026 adjusted EBITDA margin reached 36.7%, while free… The bear view: Legacy revenue still contracts. Q2 2026 print and distribution sales fell 15.0% year over year to $34.6 million; total revenue grew only 2.8%, as reported on 2026-07-30. Q2 release Transaction activity remains a dependency. The 2026-07-30 outlook includes $45 million–$50 million… Both cases follow in full.

Bull Case

• Software gained revenue share. The 2026-07-30 release reported Q2 software sales of $99.4 million, up 7.8% year over year, representing 44.3% of revenue versus 42.3% a year earlier. Q2 release
• Margins and cash improved. Q2 2026 adjusted EBITDA margin reached 36.7%, while free cash flow reached $61.2 million, up 18.4% year over year, according to the 2026-07-30 release. Q2 release

Bear Case

• Legacy revenue still contracts. Q2 2026 print and distribution sales fell 15.0% year over year to $34.6 million; total revenue grew only 2.8%, as reported on 2026-07-30. Q2 release
• Transaction activity remains a dependency. The 2026-07-30 outlook includes $45 million–$50 million of Q3 capital-markets transactional revenue. A result below $45 million would breach that component of management’s guidance. Q2 release
• Insider notice is limited evidence. The 2026-08-19 CEO Daniel Leib Form 144, attributed in the 2026-08-30 published coverage to StockTitan and GuruFocus, disclosed a proposed sale. That notice does not establish execution or demonstrate sustained insider distribution.

Setup & Price Structure

The 2026-09-11 adjusted close of $47.95 stood 14.2% below the same series’ $55.90 52-week high, despite the reported three-month gain of 24.7%. Those measured observations describe a recovery below its high; they do not establish a breakout. The $44 weekly-close threshold remains the published structural invalidation condition, rather than a newly measured support level.

The 2026-09-11 snapshot supplies neither a moving-average value nor trading-volume, short-interest or retail-participation measurements. Crowding cannot be established from the price change and RSI alone. The dated insider notice supplies a possible source of stock supply, but the sample is too small to support a claim about persistent selling pressure.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Q3 reporting period ends. This closes the period covered by management’s 2026-07-30 guidance; quarter-end itself does not disclose whether those conditions were met.

As of 2026-09-13, no company-confirmed results date within the next 30 days was verified. The retrieved events page supplied no upcoming event date. The Q3 release remains the operating test, but its date is unconfirmed; the earlier publication’s estimated October scheduling dates are not company commitments. Company events calendar

What Would Change Our Mind

Loss of the published structural threshold would end the recovery thesis: a weekly close below $44 in the adjusted market series constitutes invalidation. Independently, Q3 revenue at or below management’s $175 million guidance floor together with transactional revenue below $45 million would break the operating case. Software growth below the Q2 2026 pace of 7.8% or an adjusted EBITDA margin below the guided 26% floor would leave the stated confirmation test unmet.

The evidence supports medium conviction: the 2026-07-30 release documents improving mix and profitability, while the 2026-09-11 price snapshot remains below its adjusted annual high. Neither observation supplies a measured success probability; the conviction tier is a forecast against the explicit operating test and weekly-close invalidation.

Correlation Notes

This is a single-company software-transition thesis. The 2026-07-30 guidance explicitly ties part of revenue to capital-markets transactions, supporting an inferred exposure to issuance activity. That business exposure does not establish a statistical correlation with financial stocks, software shares or artificial-intelligence infrastructure. No paired return series is supplied as of 2026-09-11, so a market-correlation coefficient or group-led price claim is unsupported.